Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
Hans‐Henrik Parving
ResearcherPublications, citations & collaboration network
Hans‐Henrik Parving is a researcher indexed in ScholarIQ from OpenAlex & ORCID. ScholarIQ records 302 works, 29,794 citations, an h-index of 85 and an i10-index of 216.
302
Works
29,794
Citations
85
h-index
216
i10-index
IDs:OpenAlex
How has Hans‐Henrik Parving's publication output changed over time?
ScholarIQpublication output · 1983–2019
Output grew100% over the shown period — from 1 works in 1983 to 2 in 2019.
1
2
1
1
1
2
1
1
2
198320012002200320042008201220132019
What are the most-cited papers on Hans‐Henrik Parving?
ScholarIQmost cited works
Effect of a Multifactorial Intervention on Mortality in Type 2 Diabetes
Peter Gæde, Henrik Lund‐Andersen, Hans‐Henrik Parving, Oluf Pedersen
New England Journal of Medicine. 20083,476 CitationsOPEN ACCESS
[Effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes].
Hans‐Henrik Parving, Hendrik Lehnert, Jens Brøchner‐Mortensen, Ramón Gomis, Steen Andersen, Peter Arner
PubMed. 20012,531 Citations
Cardiorenal End Points in a Trial of Aliskiren for Type 2 Diabetes
Hans‐Henrik Parving, Barry M. Brenner, John J.V. McMurray, Dick de Zeeuw, Steven M. Haffner, Scott D. Solomon, Nish Chaturvedi, Frederik Persson, Akshay S. Desai, Maria Nicolaides, Alexia Richard, Zhihua Xiang, Patrick Brunel, Marc A. Pfeffer
New England Journal of Medicine. 20121,325 CitationsOPEN ACCESS
Aliskiren Combined with Losartan in Type 2 Diabetes and Nephropathy
Hans‐Henrik Parving, Frederik Persson, Julia B. Lewis, Edmund J. Lewis, Norman K. Hollenberg
New England Journal of Medicine. 20081,105 CitationsOPEN ACCESS
Bardoxolone Methyl in Type 2 Diabetes and Stage 4 Chronic Kidney Disease
Dick de Zeeuw, Tadao Akizawa, Paul Audhya, George L. Bakris, Melanie Chin, Heidi Christ‐Schmidt, Angie Goldsberry, Mark T. Houser, Melissa Krauth, Hiddo J.L. Heerspink, John J.V. McMurray, Colin J. Meyer, Hans‐Henrik Parving, Giuseppe Remuzzi, Robert D. Toto, Nosratola D. Vaziri, Christoph Wanner, Janet Wittes, Danielle Wrolstad, Glenn M. Chertow
New England Journal of Medicine. 20131,001 CitationsOPEN ACCESS
Related on ScholarIQ
University of Copenhagen
Institution
Effect of a Multifactorial Intervention on Mortality in Type 2 Diabetes
Paper
[Effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes].
Paper
Cardiorenal End Points in a Trial of Aliskiren for Type 2 Diabetes
Paper
Aliskiren Combined with Losartan in Type 2 Diabetes and Nephropathy
Paper
Bardoxolone Methyl in Type 2 Diabetes and Stage 4 Chronic Kidney Disease
Paper